National Fibromyalgia & Chronic Pain Association Funds Research and Sponsors ‘Together Walks’

National Fibromyalgia & Chronic Pain Association Funds Research and Sponsors ‘Together Walks’
After the U.S. Centers for Disease Control (CDC) published its Guidelines for Prescribing Opioids 2016 in March 15, 2016, restricting access to opioid medications, the National Fibromyalgia & Chronic Pain Association (NFMCPA), an organization that provides support, education, research and advocacy for patients of fibromyalgia (FM) and chronic pain, believes it is crucial to raise awareness and increase scientific research funding for multidisciplinary treatment approaches for pain. As such, the organization has started sponsoring ‘Together Walks’ during the month of May, across the United States. It is estimated that between 2% and 4% (10 million) of the U.S. population suffers from FM – a disease in which patients suffer from long-term body-wide pain, fatigue, sleep disturbances, memory problems and impaired functionality overall. Effective treatments are yet to be found and the majority of people with FM or chronic pain rely on opioid medications to manage their disease’s symptoms. In addition, “one hundred million American adults live with the disease of chronic pain, and many of them rely on a combination of therapies to function,” NFMCPA’s President, Jan Chambers, stated in a press release. “That combination treatment often includes strong pain medications.”
Subscribe or to access all post and page content.